Page last updated: 2024-10-22

alfuzosin and Prostatism

alfuzosin has been researched along with Prostatism in 10 studies

alfuzosin: structure given in first source

Prostatism: Lower urinary tract symptom, such as slow urinary stream, associated with PROSTATIC HYPERPLASIA in older men.

Research Excerpts

ExcerptRelevanceReference
"The aim of this study was to compare the efficacy and safety of alfuzosin (Alf) and tamsulosin (Tam) in patients with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH)."9.15Randomized crossover comparison of tamsulosin and alfuzosin in patients with urinary disturbances caused by benign prostatic hyperplasia. ( Atahan, Ö; Budak, YU; Karadağ, E; Öner, S, 2011)
"To assess the 3-year efficacy and safety of the selective alpha(1)-blocker alfuzosin at 10 mg once daily in men with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in 'real-life practice'."7.74Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice. ( Alcaraz, A; Elhilali, M; Emberton, M; Hartung, R; Harving, N; Matzkin, H; Vallancien, G; van Moorselaar, RJ, 2008)
"To evaluate the efficacy of alfuzosin treatment on voiding and storage in patients with lower urinary tract symptoms (LUTS)/benign prostatic hyperplasia (BPH) with respect to bladder outlet obstruction and contractility."5.15The long-term effect of alfuzosin in patients with lower urinary tract symptoms suggestive of benign prostate hyperplasia: evaluation of voiding and storage function with respect to bladder outlet obstruction grade and contractility. ( Cho, JS; Choo, MS; Han, JY; Kim, JC; Lee, KS; Lee, YS; Song, K, 2011)
"The aim of this study was to compare the efficacy and safety of alfuzosin (Alf) and tamsulosin (Tam) in patients with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH)."5.15Randomized crossover comparison of tamsulosin and alfuzosin in patients with urinary disturbances caused by benign prostatic hyperplasia. ( Atahan, Ö; Budak, YU; Karadağ, E; Öner, S, 2011)
"To determine the effect of alfuzosin on sexual function by using the Male Sexual Health Questionnaire (MSHQ) in men with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH)."5.14An open, non-comparative, multicentre study on the impact of alfuzosin on sexual function using the Male Sexual Health Questionnaire in patients with benign prostate hyperplasia. ( Cheon, J; Chung, BH; Chung, MK; Kim, MK; Kim, SW; Lee, JY; Lee, KS; Lee, SW; Park, JK; Park, K, 2010)
"To assess the 3-year efficacy and safety of the selective alpha(1)-blocker alfuzosin at 10 mg once daily in men with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in 'real-life practice'."3.74Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice. ( Alcaraz, A; Elhilali, M; Emberton, M; Hartung, R; Harving, N; Matzkin, H; Vallancien, G; van Moorselaar, RJ, 2008)

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (40.00)29.6817
2010's6 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barkin, J1
Diles, D1
Franks, B1
Berner, T1
Fusco, F1
Palmieri, A1
Ficarra, V1
Giannarini, G1
Novara, G1
Longo, N1
Verze, P1
Creta, M1
Mirone, V1
Roumeguère, T1
Zouaoui Boudjeltia, K1
Hauzeur, C1
Schulman, C1
Vanhaeverbeek, M1
Wespes, E1
Kim, MK1
Cheon, J1
Lee, KS2
Chung, MK1
Lee, JY1
Lee, SW1
Kim, SW1
Chung, BH1
Park, K1
Park, JK1
Song, K1
Choo, MS1
Han, JY1
Lee, YS1
Kim, JC1
Cho, JS1
Karadağ, E1
Öner, S1
Budak, YU1
Atahan, Ö1
Giannakopoulos, XK1
Giotis, C1
Karkabounas, SCh1
Verginadis, II1
Simos, YV1
Peschos, D1
Evangelou, AM1
Geppetti, P1
Nassini, R1
Materazzi, S1
Benemei, S1
Nickel, JC1
Vallancien, G1
Emberton, M1
Alcaraz, A1
Matzkin, H1
van Moorselaar, RJ1
Hartung, R1
Harving, N1
Elhilali, M1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Prophylactic Tamsulosin in Prevention of Post-operative Urinary Retention in Men After Transanal Endoscopic Microsurgery: A Multicenter Randomized, Double-blind, Placebo-controlled Clinical Trial[NCT03314025]Phase 2158 participants (Anticipated)Interventional2017-10-06Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

4 reviews available for alfuzosin and Prostatism

ArticleYear
α1-Blockers Improve Benign Prostatic Obstruction in Men with Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis of Urodynamic Studies.
    European urology, 2016, Volume: 69, Issue:6

    Topics: Adrenergic alpha-1 Receptor Antagonists; Clinical Trials as Topic; Doxazosin; Humans; Indoles; Male;

2016
Is there a rationale for the chronic use of phosphodiesterase-5 inhibitors for lower urinary tract symptoms secondary to benign prostatic hyperplasia?
    BJU international, 2009, Volume: 104, Issue:4

    Topics: Aged; Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Middle Aged; Phosphodiesterase Inh

2009
The concept of neurogenic inflammation.
    BJU international, 2008, Volume: 101 Suppl 3

    Topics: Adrenergic alpha-Antagonists; Animals; Calcium Channels; Humans; Male; Nerve Tissue Proteins; Neurog

2008
Role of alpha1-blockers in chronic prostatitis syndromes.
    BJU international, 2008, Volume: 101 Suppl 3

    Topics: Adrenergic alpha-Antagonists; Anti-Infective Agents; Bacterial Infections; Chronic Disease; Clinical

2008

Trials

4 trials available for alfuzosin and Prostatism

ArticleYear
An open, non-comparative, multicentre study on the impact of alfuzosin on sexual function using the Male Sexual Health Questionnaire in patients with benign prostate hyperplasia.
    International journal of clinical practice, 2010, Volume: 64, Issue:3

    Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Ejaculation; Humans; Male; Middle Aged; Patient Satis

2010
The long-term effect of alfuzosin in patients with lower urinary tract symptoms suggestive of benign prostate hyperplasia: evaluation of voiding and storage function with respect to bladder outlet obstruction grade and contractility.
    Urology, 2011, Volume: 77, Issue:5

    Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Humans; Male; Middle Aged; Muscle

2011
Randomized crossover comparison of tamsulosin and alfuzosin in patients with urinary disturbances caused by benign prostatic hyperplasia.
    International urology and nephrology, 2011, Volume: 43, Issue:4

    Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Cross-Over Studies; Humans; Male; Middle Aged; Prosta

2011
Effects of pulsed electromagnetic fields on benign prostate hyperplasia.
    International urology and nephrology, 2011, Volume: 43, Issue:4

    Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Electromagnetic Fields; Humans; Male; Organ Size; Pro

2011

Other Studies

2 other studies available for alfuzosin and Prostatism

ArticleYear
Alpha blocker monotherapy versus combination therapy with antimuscarinics in men with persistent LUTS refractory to alpha-adrenergic treatment: patterns of persistence.
    The Canadian journal of urology, 2015, Volume: 22, Issue:4

    Topics: Administrative Claims, Healthcare; Adrenergic alpha-Antagonists; Aged; Benzofurans; Doxazosin; Drug

2015
Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice.
    BJU international, 2008, Volume: 101, Issue:7

    Topics: Adrenergic alpha-Antagonists; Aged; Disease Progression; Erectile Dysfunction; Humans; Male; Nocturi

2008